Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 150,000 shares at $51.32 ($7.9M) on 2019-12-05, disclosed to the SEC on 2019-12-06.
Open-market sale of $7.9M ACAD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.32 | 28,256 | $1.5M | 18.5% |
| 2 | $52.09 | 40,159 | $2.1M | 26.6% |
| 3 | $52.82 | 81,585 | $4.3M | 54.9% |
| Total | $52.34 avg | 150,000 | $7.9M | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |